Millennium Management’s United Therapeutics UTHR Stock Holding History

Millennium Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$43M	Buy	+72,500	New	+$36.1M	0.02%	939
2024 Q4	–	Sell	-6,800	Closed	-$2.44M	–	6483
2024 Q3	$2.44M	Buy	6,800 +2,900	+74%	+$980K	﹤0.01%	3525
2024 Q2	$1.24M	Buy	+3,900	New	+$1.03M	﹤0.01%	3943
2022 Q2	–	Sell	-25,000	Closed	-$4.49M	–	7532
2022 Q1	$4.49M	Buy	+25,000	New	+$4.76M	﹤0.01%	3055
2021 Q4	–	Sell	-60,000	Closed	-$11.1M	–	7408
2021 Q3	$11.1M	Buy	+60,000	New	+$11.8M	0.01%	1928
2021 Q2	–	Sell	-50,000	Closed	-$8.36M	–	7137
2021 Q1	$8.36M	Buy	+50,000	New	+$8.34M	0.01%	1986
2020 Q2	–	Sell	-20,000	Closed	-$1.9M	–	4615
2020 Q1	$1.9M	Sell	20,000 -80,000	-80%	-$7.6M	﹤0.01%	2059
2019 Q4	$8.81M	Sell	100,000 -50,000	-33%	-$4.4M	0.01%	1483
2019 Q3	$12M	Buy	+150,000	New	+$12.1M	0.02%	1155
2018 Q3	–	Sell	-30,000	Closed	-$3.4M	–	4298
2018 Q2	$3.4M	Buy	+30,000	New	+$3.3M	﹤0.01%	2055
2017 Q4	–	Sell	-7,300	Closed	-$855K	–	4095
2017 Q3	$855K	Buy	+7,300	New	+$932K	﹤0.01%	2600
2016 Q1	–	Sell	-50,000	Closed	-$7.83M	–	3682
2015 Q4	$7.83M	Buy	+50,000	New	+$7.28M	0.02%	1064
2015 Q1	–	Sell	-20,000	Closed	-$2.59M	–	4133
2014 Q4	$2.59M	Buy	+20,000	New	+$2.58M	0.01%	1807

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Millennium Management's UTHR Position: Q1 2026 in Review

Millennium Management increased its United Therapeutics (UTHR) stake by 139% in Q1 2026, buying an estimated $44.5M and bringing the position to 153,372 shares worth $90.9M. The position accounts for 0.04% of the portfolio, ranked #488.

Millennium Management first reported a position in UTHR in Q2 2013 and has held it in 50 quarters since. The position peaked at $141M in Q4 2022. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

Millennium Management held 153,372 shares of United Therapeutics worth $90.9M as of Q1 2026.
Millennium Management bought 89,299 United Therapeutics shares in Q1 2026, an estimated $44.5M.
United Therapeutics made up 0.04% of Millennium Management's portfolio in Q1 2026, its #488 holding.
Millennium Management first reported a position in United Therapeutics in Q2 2013 and has held it in 50 quarters since.
Millennium Management's United Therapeutics position peaked at $141M in Q4 2022.
850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.